Security key
29664W105
- Security type / class
- Equity / COM
- Total 13F shares
- 30,817,874
- Total 13F value
- $1,207,760,885
- Share change
- +4,494,690
- Put/Call ratio
- 342%
- SEC-reported price per share
- $39.19
- Number of holders
- 151
- Value change
- +$133,006,694
- Number of buys
- 87
- Number of sells
- 92
- Shares outstanding
- 275,740,714
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2018
Institutions
151
Top holders
10
Broader feeds
Ownership snapshot
Top reported holders of ESPR - Esperion Therapeutics, Inc. - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
—
Disclosed value leader
—
Comparable rows
0/0
Latest evidence
—
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
13F holder rows
Institutional holders as of Q2 2018
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
151
Shares
30,817,874
Rows available
151
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2018 vs Q1 2018 Across Filers
Q1 2018 holders
184
Q2 2018 holders
151
Holder diff
-33
| Investor | Q1 2018 Shares | Q2 2018 Shares | Share Diff | Share Chg % | Q1 2018 value | Q2 2018 value | Value change | Value Chg % |
|---|